Expansion of medical-use HAL based at regional core hospitals
First written in FY2017-Q3. 5 of 6 entries say "Restated". Latest entry: FY2026.
No other company in this theme has enough history to compare yet.
- FY2026RestatedAnnual report
「We are developing the business in collaboration with the Group and business partners in each region, positioning it as a hub for medical and healthcare services for individuals.」
The company has reaffirmed its policy of developing the Robocare business in collaboration with regional business partners as a base for medical and healthcare services for individuals. - FY2019-Q1RestatedAnnual report
「In the medical field, the HAL® Medical Lower Limb Type Bilateral Model, designed to improve walking function, continues to be introduced mainly at domestic core hospitals for publicly insured medical treatment of intractable neuromuscular diseases.」
The company has reaffirmed its policy of promoting the introduction of medical-use HAL, centered on domestic core hospitals, against the backdrop of public health insurance coverage. - FY2018RestatedAnnual report
「The Group will continue to establish core medical centers for neuromuscular intractable diseases and accelerate clinical trials and investigator-initiated clinical trials for other diseases, including stroke and spinal disorders, to expand the applications of cybernics treatment.」
The company has reaffirmed its policy of introducing medical-use HAL centered on domestic core hospitals and expanding into each region by establishing core medical facilities. - FY2018-Q2RestatedAnnual report
「Since public health insurance treatment for neuromuscular intractable diseases began in September 2016, the medical-use HAL® lower-limb type (bilateral-leg model) has been increasingly adopted, mainly by designated hospitals in Japan.」
The company has reaffirmed its approach of promoting the introduction of medical-use HAL, centered on domestic core hospitals, against the backdrop of public health insurance coverage. - FY2017RestatedAnnual report
「We will continue to expand the business successively while establishing core hospitals as bases in each region.」
The company has reaffirmed its policy of expanding the introduction of medical-use HAL based at regional core hospitals. - FY2017-Q3First statedAnnual report
「Going forward, we plan to expand the business successively while establishing core hospitals as bases in each region.」
The company has, for the first time, clearly stated its approach of using core hospitals in each region as bases for expanding the introduction of medical-use HAL.